Belimumab News

Belimumab currently has 12 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Belimumab with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Original indication: Benlysta is indicated as add-on therapy in patients aged 5 years and older with active, autoantibody-positive systemic lupus erythematosus (SLE) with a high degree of disease activity (e.g.,...
Evidence level: L5
Predicted indications (20):
- primary release disorder of platelets (100.0%)
- pseudo-von Willebrand disease (100.0%)
- Glanzmann thrombasthenia (99.9%)
- fetal and neonatal alloimmune thrombocytopenia (99.6%)
- severe nonproliferative diabetic retinopathy (99.0%)
- autosomal dominant macrothrombocytopenia (99.0%)
- granulomatous disease, chronic, autosomal recessive, 5 (97.9%)
- anus disease (97.9%)
- inflammatory bowel disease (97.8%)
- granulomatous disease with defect in neutrophil chemotaxis (97.7%)
- Scott syndrome (97.4%)
- functional neutrophil defect (97.2%)
- congenital hypotrichosis with juvenile macular dystrophy (97.0%)
- systemic sclerosis (96.7%)
- psoriasis (96.7%)
- bleeding diathesis due to a collagen receptor defect (96.7%)
- hemorrhagic disorder due to a constitutional thrombocytopenia (96.6%)
- Crohn disease of the esophagus (96.5%)
- ulcerative colitis (disease) (96.5%)
- cyclic hematopoiesis (96.0%)